Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Outlook Therapeutics, Inc. - Common Stock (NQ: OTLK )

1.870 +0.030 (+1.63%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 735,967
Open 1.880
Bid (Size) 1.890 (1)
Ask (Size) 1.930 (3)
Prev. Close 1.840
Today's Range 1.830 - 1.990
52wk Range 0.8700 - 12.85
Shares Outstanding 24,905,635
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug
Outlook Therapeutics plans to resubmit ONS-5010 for FDA approval in 2025 following NORSE EIGHT trial results in wet AMD patients. 
Via Benzinga
Exposures Product Safety
Top 3 Health Care Stocks That Could Blast Off This Month
Via Benzinga

Performance

YTD
-9.22%
-9.22%
1 Month
-14.61%
-14.61%
3 Month
-63.72%
-63.72%
6 Month
-73.88%
-73.88%
1 Year
-79.30%
-79.30%

More News

Read More
This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Nasdaq Down Over 100 Points; HP Shares Plunge
Via Benzinga
Dow Falls Over 100 Points; US Crude Oil Stocks Decline
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
US Stocks Mixed; Economy Grows By 2.8% In Q3
Via Benzinga
Topics Economy
Exposures Economy
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?
Via Benzinga
OUTLOOK ALERT: Bragar Eagel & Squire, P.C. is Investigating Outlook Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024
Via InvestorPlace
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
Via MarketBeat
3 Undervalued Gems Set to Soar 1,000% by 2026
Via InvestorPlace
MarketBeat Week in Review – 6/17 - 6/21
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
Via MarketBeat
OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024
Via InvestorPlace
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
Via InvestorPlace
Insiders Buying Outlook Therapeutics And 2 Other Stocks
Via Benzinga
Gold Moves Lower; Lululemon Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday?
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.